Filing Overview
This Form 6-K was filed by I-MAB, a foreign private issuer, for June 2021, with a filing date of June 25, 2021. The provided filing text identifies I-MAB—not Novabridge Biosciences—as the registrant. I-MAB reports under Form 20-F. The filing references Exhibit 99.1, a press release, but the press release text is not included.
Financial and Operating Metrics
The provided filing text does not contain revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide information on changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. Any such information may be contained in the referenced Exhibit 99.1, which was not provided.
Investor Verification Items
- Verify the registrant identity: the filing names I-MAB, while the request identifies Novabridge Biosciences.
- Obtain and review Exhibit 99.1, the referenced press release.
- Verify the filing’s underlying business, financial, and event disclosures from the complete submission.
- Confirm whether the June 25, 2021 date refers to the filing date or an event date described in the omitted exhibit.